Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Buy
150,285
+5,420
+4% +$16.9K 0.21% 76
2026
Q1
$423K Buy
144,865
+14,225
+11% +$40.6K 0.22% 75
2025
Q4
$323K Buy
130,640
+3,005
+2% +$7.16K 0.16% 93
2025
Q3
$285K Buy
127,635
+7,735
+6% +$17.7K 0.14% 98
2025
Q2
$289K Buy
119,900
+5,880
+5% +$14.3K 0.15% 98
2025
Q1
$266K Buy
114,020
+16,230
+17% +$32.5K 0.16% 100
2024
Q4
$181K Buy
97,790
+16,435
+20% +$36.4K 0.11% 106
2024
Q3
$199K Buy
81,355
+27,580
+51% +$61.9K 0.13% 107
2024
Q2
$110K Buy
53,775
+29,515
+122% +$67.2K 0.08% 102
2024
Q1
$60.2K Buy
+24,260
New +$63.2K 0.05% 101

Other funds holding ABEV

Wynn Capital's ABEV Position: Q2 2026 in Review

Wynn Capital increased its Ambev (ABEV) stake by 3.7% in Q2 2026, buying an estimated $16.9K and bringing the position to 150,285 shares worth $472K. The position accounts for 0.21% of the portfolio, ranked #76.

Wynn Capital first reported a position in ABEV in Q1 2024 and has held it in 10 quarters since. 141 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Wynn Capital held 150,285 shares of Ambev worth $472K as of Q2 2026.
  • Wynn Capital bought 5,420 Ambev shares in Q2 2026, an estimated $16.9K.
  • Ambev made up 0.21% of Wynn Capital's portfolio in Q2 2026, its #76 holding.
  • Wynn Capital first reported a position in Ambev in Q1 2024 and has held it in 10 quarters since.
  • 141 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Wynn Capital's 13F filing for Q2 2026, filed 8 Jul 2026.